The OEBA Study: Observation of Early Bactericidal Activity of Standard TB Treatment

A PanACEA Capacity Development Project

MMRC: Site Principal Investigator: Andrea Rachow, MD, Co-Site PI: Issa Sabi

Munich: Protocol Chair: Norbert Heinrich

Purpose
Early Bactericidal Activity (EBA) Studies are currently the eye of the needle in the anti-TB drug development process, with limited site capacity slowing down phase 2 testing of new anti-TB drug candidates. To address this problem, PanACEA (Pan-African Consortium for Evaluation of Antituberculosis Antibiotics) has decided to develop a Tanzanian EBA facility consisting of MMRC and Kilimanjaro Clinical Research Institute (KCRI).

OEBA is designed as a platform to establish capacity for Early Bactericidal Activity Studies in these sites, and will provide the opportunity to research additional questions around TB treatment and monitoring of treatment success.

 

Approach
The sites are developing their inpatient facilities, train laboratory and clinical staff, and demonstrate the capabilities within this two-site study, which will apply the methodologies to patients newly started on standard anti-TB treatment. The results of this study will demonstrate that EBA studies are feasible in the two-site setting in Tanzania.

Results
Tthe protocol has been finalized in 3Q 2010, and is currently undergoing ethical review.

Sponsors
Tthe study is sponsored by the European and Developing Countries Clinical Trials Partnership (EDCTP), within the PanACEA capacity development plan.

Partners
Kilimanjaro Clinical Research Institute, Radboud University Nijmegen, the Netherlands, University College of London

Publications
no publications yet

You can reach us at:

NIMR - Mbeya Medical Research Center
P.O Box 2410
Hospital Hill rd, Mbeya Tanzania

Tel +255 25 250 3364
Fax +255 25 250 3134

Working hours:
Mon - Fri
08:00 - 17:00 EAT (GMT + 3)

Or send us an email at This email address is being protected from spambots. You need JavaScript enabled to view it.

Our Twitter Feed

NIMRMbeya RT @TBtrials_StAnd: “We MUST run faster than the diseases through prevention & management factoring multidisciplinary approaches collaborat…
15mreplyretweetfavorite
NIMRMbeya Deputy Minister MoHCDGEC Dr. Faustine Ndugulile (sitted at the center) in a group photo with members of the Execu… https://t.co/g6GVYT9mu3
9hreplyretweetfavorite
NIMRMbeya Deputy Minister MoHCDGEC Dr. Faustine Ndugulile giving a commencement speech for the annual PanACEA Consortium mee… https://t.co/p3XGG56KBd
9hreplyretweetfavorite
NIMRMbeya RT @PanACEA_II: The 10th PanACEA Annual Meeting in Mbeya, TZ is officially opened by centre director Dr Ntingya, council chair Dr Mtasiwa,…
10hreplyretweetfavorite
NIMRMbeya RT @SabiitiwWilber: The PanACEA 10th forum opens with exciting opening remarks from Dr Ntinginya, Prof Bouree, Prof Mgaya-NIMR director, NI…
10hreplyretweetfavorite
© 2017 NIMR - Mbeya Medical Research Center